US 2020/0390903 A1Published application

Plectin-targeted liposomes/parp inhibitor in the treatment of cancer

AssigneeUniversity of Virginia Patent Foundation

InventorsKimberly A. Kelly, Siva Sai Krishna Dasa

Life of this patent

Estimating the term…

Abstract

The present invention provides compositions and methods to treat cancer.

Claims15

Dependent claims

A composition comprising a Plectin Targeted Peptide (PTP) conjugated-nanoparticle, wherein the PTP is on the surface of the nanoparticle and the nanoparticle encapsulates a payload.

Dependencies are inferred from the claim text.

Facts

Application: 16/971,095Filed 27 Feb 2019
Priority: 27 Feb 2018
Published: 17 Dec 2020
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 47/6911
The form being a colloid or an emulsion: the form being a liposome
A61K 31/282
Compounds containing heavy metals: platinum compounds
A61K 31/337
Having oxygen as the only ring hetero atom, e.g. fungichromin: having four-membered rings, e.g. taxol
A61K 31/498
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrazines or piperazines…

Family

Application62/635,676Us provisional application · filed 27 Feb 2018
US 11,890,352 B2Related patent
US 2020/0390903 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results